Book contents
- The Cambridge Handbook of Personality Disorders
- The Cambridge Handbook of Personality Disorders
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Preface
- Part I Etiology
- Part II Models
- Part III Individual Disorders and Clusters
- Part IV Assessment
- Part V Treatment
- 17 Cognitive Behavioral Approaches
- 17a Applying a Cognitive-Behavioral, Principle-Based Approach to the Treatment of Personality Disorders: Commentary on Cognitive Behavioral Approaches
- 17b Implementation Challenges in Real World Settings: Commentary on Cognitive Behavioral Approaches
- 17c Further Considerations about Cognitive Behavioral Therapies and Personality Disorders: Author Rejoinder to Commentaries on Cognitive Behavioral Approaches
- 18 Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18a Contemporary Psychodynamic Treatments: Commentary on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18b Consideration of Commonalities in Distinct Models of Treatment for Individuals with Borderline Personality Disorder: Commentary on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18c Further Development of Three Key Issues: Author Rejoinder to Commentaries on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 19 Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19a A Functional Understanding of the Relationship between Personality and Clinical Diagnoses and Implications for Treatment Planning: Commentary on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19b The Need for Mechanistic Models to Translate Traits from Bench to Bedside: Commentary on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19c Simplicity and Dynamics of the ICD-11 Trait Qualifiers in Relation to Treatment: Author Rejoinder to Commentaries on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 20 Brief Therapeutic Approaches for Personality Disorders
- 20a What Knowledge Is Lacking on Brief Interventions for Personality Disorders and Why: Commentary on Brief Therapeutic Approaches for Personality Disorders
- 20b Short- and Long-Term Personality Disorder Treatment Studies Should Inform One Another: Commentary on Brief Therapeutic Approaches for Personality Disorders
- 20c Next Steps: Author Rejoinder to Commentaries on Brief Therapeutic Approaches for Personality Disorders
- 21 Recent Developments in the Pharmacologic Management of Personality Disorders
- 21a New Efforts towards Evidence-Informed Practice and Practice-Informed Research: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders
- 21b Considerations Regarding the Pharmacological Management of Personality Disorders: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders
- 21c Directions for Future Drug Trial Research: Author Rejoinder to Commentaries on Recent Developments in the Pharmacologic Management of Personality Disorders
- Index
- References
18c - Further Development of Three Key Issues: Author Rejoinder to Commentaries on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
from Part V - Treatment
Published online by Cambridge University Press: 24 February 2020
Book contents
- The Cambridge Handbook of Personality Disorders
- The Cambridge Handbook of Personality Disorders
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Preface
- Part I Etiology
- Part II Models
- Part III Individual Disorders and Clusters
- Part IV Assessment
- Part V Treatment
- 17 Cognitive Behavioral Approaches
- 17a Applying a Cognitive-Behavioral, Principle-Based Approach to the Treatment of Personality Disorders: Commentary on Cognitive Behavioral Approaches
- 17b Implementation Challenges in Real World Settings: Commentary on Cognitive Behavioral Approaches
- 17c Further Considerations about Cognitive Behavioral Therapies and Personality Disorders: Author Rejoinder to Commentaries on Cognitive Behavioral Approaches
- 18 Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18a Contemporary Psychodynamic Treatments: Commentary on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18b Consideration of Commonalities in Distinct Models of Treatment for Individuals with Borderline Personality Disorder: Commentary on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18c Further Development of Three Key Issues: Author Rejoinder to Commentaries on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 19 Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19a A Functional Understanding of the Relationship between Personality and Clinical Diagnoses and Implications for Treatment Planning: Commentary on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19b The Need for Mechanistic Models to Translate Traits from Bench to Bedside: Commentary on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19c Simplicity and Dynamics of the ICD-11 Trait Qualifiers in Relation to Treatment: Author Rejoinder to Commentaries on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 20 Brief Therapeutic Approaches for Personality Disorders
- 20a What Knowledge Is Lacking on Brief Interventions for Personality Disorders and Why: Commentary on Brief Therapeutic Approaches for Personality Disorders
- 20b Short- and Long-Term Personality Disorder Treatment Studies Should Inform One Another: Commentary on Brief Therapeutic Approaches for Personality Disorders
- 20c Next Steps: Author Rejoinder to Commentaries on Brief Therapeutic Approaches for Personality Disorders
- 21 Recent Developments in the Pharmacologic Management of Personality Disorders
- 21a New Efforts towards Evidence-Informed Practice and Practice-Informed Research: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders
- 21b Considerations Regarding the Pharmacological Management of Personality Disorders: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders
- 21c Directions for Future Drug Trial Research: Author Rejoinder to Commentaries on Recent Developments in the Pharmacologic Management of Personality Disorders
- Index
- References
Summary
This rejoinder begins with an expression of gratitude and broad agreement with the two commentaries by Kenneth Levy and Nicholas Salsman. The rejoinder considers three main issues: (1) the fact of the range of psychodynamic treatments that have been found to be effective in the treatment of personality disorder (PD); (2) the value of considering a dimensional approach to psychopathology in general and PD more specifically, particularly in the context of recent work on the general psychopathology factor; and (3), the issue of transference and different ways of approaching it across different psychodynamic treatments.
Keywords
- Type
- Chapter
- Information
- The Cambridge Handbook of Personality Disorders , pp. 448 - 449Publisher: Cambridge University PressPrint publication year: 2020
References
Beauchaine, T. P., & Cicchetti, D. (2016). A new generation of comorbidity research in the era of neuroscience and Research Domain Criteria. Development and Psychopathology, 28(4 Pt 1), 891–894.CrossRefGoogle ScholarPubMed
Caspi, A., & Moffitt, T. E. (2018). All for one and one for all: Mental disorders in one dimension. American Journal of Psychiatry, 175(9), 831–844.Google Scholar
Copeland, W. E., Shanahan, L., Erkanli, A., Costello, E. J., & Angold, A. (2013). Indirect comorbidity in childhood and adolescence. Frontiers in Psychiatry, 4, 144.Google Scholar
Cristea, I. A., Gentili, C., Cotet, C. D., Palomba, D., Barbui, C., & Cuijpers, P. (2017). Efficacy of psychotherapies for borderline personality disorder: A systematic review and meta-analysis. JAMA Psychiatry, 74(4), 319–328.Google Scholar
Fonagy, P., Luyten, P., Allison, E., & Campbell, C. (2017a). What we have changed our minds about: Part 1. Borderline personality disorder as a limitation of resilience. Borderline Personality Disorder and Emotional Dysregulation, 4, 11. doi:10.1186/s40479-017-0061-9Google Scholar
Fonagy, P., Luyten, P., Allison, E., & Campbell, C. (2017b). What we have changed our minds about: Part 2. Borderline personality disorder, epistemic trust and the developmental significance of social communication. Borderline Personality Disorder and Emotional Dysregulation, 4, 9. doi:10.1186/s40479-017-0062-8Google Scholar
Forbes, M. K., Tackett, J. L., Markon, K. E., & Krueger, R. F. (2016). Beyond comorbidity: Toward a dimensional and hierarchical approach to understanding psychopathology across the life span. Development and Psychopathology, 28(4 Pt 1), 971–986.Google Scholar
Gunderson, J. G., & Links, P. (2014). Handbook of Good Psychiatric Management for Borderline Personality Disorder. Washington, DC: American Psychiatric Press.Google Scholar
Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627.Google Scholar
McMain, S. F., Guimond, T., Streiner, D. L., Cardish, R. J., & Links, P. S. (2012). Dialectical behavior therapy compared with general psychiatric management for borderline personality disorder: Clinical outcomes and functioning over a 2-year follow-up. American Journal of Psychiatry, 169(6), 650–661.Google Scholar
McMain, S. F., Links, P. S., Gnam, W. H., Guimond, T., Cardish, R. J., Korman, L., & Streiner, D. L. (2009). A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. American Journal of Psychiatry, 166(12), 1365–1374.Google Scholar
Merikangas, K. R., He, J. P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., … Swendsen, J. (2010). Lifetime prevalence of mental disorders in U.S. adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A). Journal of the American Academy of Child & Adolescent Psychiatry, 49(10), 980–989.Google Scholar
Sharp, C., Wright, A. G. C., Fowler, J. C., Frueh, B. C., Allen, J. G., Oldham, J., & Clark, L. (2015). Borderline personality pathology as the ‘g’ factor of personality disorder. Journal of Abnormal Psychology, 124(2), 387–398.Google Scholar
Zimmermann, M., Morgan, T. A., & Stanton, K. (2018). The severity of psychiatric disorders World Psychiatry, 17(3), 258–275.Google Scholar